92 related articles for article (PubMed ID: 29293134)
1. Bronchiectasis as a Cause of Elevated CA-19-9 Demonstrated on 18F-FDG PET/CT.
Mikhail P; Le K; Bui C; Mansberg R
Clin Nucl Med; 2018 Mar; 43(3):207-208. PubMed ID: 29293134
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT in a Patient With Pregnancy and Lactation-Associated Osteoporosis.
Chen J; Wang Q; Qiu L
Clin Nucl Med; 2018 Oct; 43(10):742-743. PubMed ID: 30188874
[TBL] [Abstract][Full Text] [Related]
3. Multicentric Reticulohistiocytosis Mimicking Malignancy on 18F-FDG PET/CT.
Hotta M; Minamimoto R; Suzuki D; Takahashi A
Clin Nucl Med; 2017 Jul; 42(7):567-568. PubMed ID: 28368895
[TBL] [Abstract][Full Text] [Related]
4. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
5. Dermoid cyst with secretion of CA 19-9 detected by 18F-FDG PET/CT: A case report.
Lin SC; Yen RF; Chen YK
Medicine (Baltimore); 2020 Mar; 99(10):e18988. PubMed ID: 32150047
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography in the prediction of inflammation in children with human immunodeficiency virus related bronchiectasis.
Masekela R; Gongxeka H; Green RJ; Sathekge M
Hell J Nucl Med; 2012; 15(1):23-7. PubMed ID: 22413108
[TBL] [Abstract][Full Text] [Related]
7. Jejunal tuberculosis: incidental finding on an FDG-PET scan.
Wang HY; Lin WY
Kaohsiung J Med Sci; 2006 Jan; 22(1):34-8. PubMed ID: 16570567
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
[TBL] [Abstract][Full Text] [Related]
9. FDG-Avid Keloid on PET/CT Imaging.
Li ZG
Clin Nucl Med; 2017 Aug; 42(8):620-621. PubMed ID: 28481801
[TBL] [Abstract][Full Text] [Related]
10. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T
Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG activitiy PET/CT and CA-19.9 levels for the prediction of histopathological features and localization of peri- ampullary tumors.
Akcam AT; Ülkü A; Rencuzoğulları A; Parsak CK; Yapar Z; Doran F; Demiryürek H; Okoh AK
Turk J Gastroenterol; 2015 Mar; 26(2):170-5. PubMed ID: 25835117
[TBL] [Abstract][Full Text] [Related]
12. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N
Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435
[TBL] [Abstract][Full Text] [Related]
13. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
[TBL] [Abstract][Full Text] [Related]
14. Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages.
Palomar Muñoz A; Cordero García JM; Talavera Rubio MDP; García Vicente AM; Pena Pardo FJ; Jiménez Londoño GA; Soriano Castrejón Á; Aranda Aguilar E
Medicine (Baltimore); 2018 Apr; 97(17):e0098. PubMed ID: 29702969
[TBL] [Abstract][Full Text] [Related]
15. SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients.
Bai L; Guo CH; Zhao Y; Gao JG; Li M; Shen C; Guo YM; Duan XY
Oncol Rep; 2017 Jun; 37(6):3433-3440. PubMed ID: 28498457
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
Trybek T; Kowalska A; Lesiak J; Młynarczyk J
Nucl Med Rev Cent East Eur; 2014; 17(2):87-93. PubMed ID: 25088108
[TBL] [Abstract][Full Text] [Related]
17. Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT.
Rakheja R; Makis W; Hickeson M
Abdom Imaging; 2012 Apr; 37(2):304-8. PubMed ID: 21394599
[TBL] [Abstract][Full Text] [Related]
18. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
19. Widespread Amyloidosis Around Major Joints on 18F-FDG PET/CT.
Shao F; Zhang M; Wang Y; Zou Y; Chen Y
Clin Nucl Med; 2017 Jan; 42(1):76-78. PubMed ID: 27801742
[TBL] [Abstract][Full Text] [Related]
20. Scrotal Fibroepithelial Polyp With Acute and Chronic Inflammation Mimics Malignancy on 18F-FDG PET/CT Imaging.
Chuang TL; Tseng CE; Huang SW; Wang YF
Clin Nucl Med; 2019 Nov; 44(11):920-922. PubMed ID: 31524677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
